Stephens Inc’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,945
| Closed | -$357K | – | 1418 |
|
|
2021
Q2 | $357K | Sell |
1,945
-773
| -28% | -$142K | 0.01% | 976 |
|
|
2021
Q1 | $416K | Sell |
2,718
-6,247
| -70% | -$956K | 0.01% | 897 |
|
|
2020
Q4 | $1.4M | Sell |
8,965
-2,141
| -19% | -$335K | 0.03% | 510 |
|
|
2020
Q3 | $1.27M | Buy |
11,106
+194
| +2% | +$22.2K | 0.03% | 490 |
|
|
2020
Q2 | $1.23M | Sell |
10,912
-591
| -5% | -$66.3K | 0.03% | 471 |
|
|
2020
Q1 | $1.03M | Sell |
11,503
-241
| -2% | -$21.6K | 0.03% | 461 |
|
|
2019
Q4 | $1.27M | Buy |
11,744
+943
| +9% | +$102K | 0.03% | 505 |
|
|
2019
Q3 | $1.06M | Sell |
10,801
-120
| -1% | -$11.8K | 0.02% | 536 |
|
|
2019
Q2 | $1.43M | Buy |
10,921
+197
| +2% | +$25.8K | 0.03% | 478 |
|
|
2019
Q1 | $1.45M | Buy |
10,724
+1,531
| +17% | +$207K | 0.03% | 481 |
|
|
2018
Q4 | $895K | Buy |
9,193
+68
| +0.7% | +$6.62K | 0.03% | 549 |
|
|
2018
Q3 | $1.27M | Buy |
+9,125
| New | +$1.27M | 0.03% | 509 |
|
|
2017
Q3 | – | Sell |
-6,683
| Closed | -$813K | – | 901 |
|
|
2017
Q2 | $813K | Buy |
6,683
+439
| +7% | +$53.4K | 0.03% | 475 |
|
|
2017
Q1 | $757K | Buy |
6,244
+3,518
| +129% | +$427K | 0.03% | 475 |
|
|
2016
Q4 | $334K | Sell |
2,726
-43
| -2% | -$5.27K | 0.01% | 583 |
|
|
2016
Q3 | $339K | Buy |
2,769
+337
| +14% | +$41.3K | 0.01% | 589 |
|
|
2016
Q2 | $284K | Buy |
2,432
+673
| +38% | +$78.6K | 0.01% | 603 |
|
|
2016
Q1 | $245K | Sell |
1,759
-163
| -8% | -$22.7K | 0.01% | 605 |
|
|
2015
Q4 | $367K | Buy |
1,922
+12
| +0.6% | +$2.29K | 0.02% | 499 |
|
|
2015
Q3 | $299K | Buy |
1,910
+136
| +8% | +$21.3K | 0.02% | 546 |
|
|
2015
Q2 | $321K | Sell |
1,774
-448
| -20% | -$81.1K | 0.01% | 586 |
|
|
2015
Q1 | $385K | Sell |
2,222
-49
| -2% | -$8.49K | 0.02% | 554 |
|
|
2014
Q4 | $420K | Buy |
2,271
+654
| +40% | +$121K | 0.02% | 540 |
|
|
2014
Q3 | $268K | Buy |
1,617
+100
| +7% | +$16.6K | 0.01% | 639 |
|
|
2014
Q2 | $237K | Buy |
1,517
+22
| +1% | +$3.44K | 0.01% | 711 |
|
|
2014
Q1 | $227K | Sell |
1,495
-40
| -3% | -$6.07K | 0.01% | 678 |
|
|
2013
Q4 | $204K | Sell |
1,535
-335
| -18% | -$44.5K | 0.01% | 770 |
|
|
2013
Q3 | $217K | Buy |
1,870
+245
| +15% | +$28.4K | 0.01% | 688 |
|
|
2013
Q2 | $150K | Buy |
+1,625
| New | +$150K | 0.01% | 666 |
|